Sign in

CIK 0001080014

  • Large accelerated filer

Innoviva, Inc.

Sign in to watch
Ticker
INVA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943265960
Phone
+1 650-238-9600
Business address
1350 OLD BAYSHORE HIGHWAY, SUITE 400, BURLINGAME, CA, 94010
Former names
THERAVANCE INC, ADVANCED MEDICINE INC
  1. 4 Grant or award Chief Financial Officer acquired 27,609 shares (grant or award)
  2. 4 Grant or award 10% owner acquired 112,296 shares (grant or award)
  3. 4 Shares withheld for taxes Chief Financial Officer gave up 237 shares (to pay taxes)
  4. 4 Shares withheld for taxes Chief Accounting Officer gave up 991 shares (to pay taxes)
  5. 4 Shares withheld for taxes Chief Accounting Officer gave up 992 shares (to pay taxes)
  6. 4 Shares withheld for taxes Chief Financial Officer gave up 237 shares (to pay taxes)
  7. 4 Grant or award Director acquired 12,077 shares (grant or award)
  8. 4 Grant or award Director acquired 12,077 shares (grant or award)
  9. 4 Grant or award Director acquired 12,077 shares (grant or award)
  10. 4 Grant or award Director acquired 12,077 shares (grant or award)
  11. 4 Grant or award Chief Accounting Officer acquired 8,938 shares (grant or award)
  12. 4 Grant or award Chief Financial Officer acquired 10,569 shares (grant or award)
  13. 4 Grant or award 10% owner acquired 37,377 shares (grant or award)
  14. 4/A Insider Changes in Ownership
  15. 4 Open-market sale 10% owner sold 1,618,295 shares at an average $17.55 ($28,395,442)
  16. 4 Shares withheld for taxes Chief Accounting Officer gave up 2,565 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chief Financial Officer gave up 1,106 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chief Accounting Officer gave up 976 shares (to pay taxes)
  19. 4 Shares withheld for taxes Chief Accounting Officer gave up 975 shares (to pay taxes)
  20. 4 Grant or award Director acquired 13,923 shares (grant or award)

Page 2 of 39 · 776 filings